PEPTIDE INDUCING ANTI-TUMOR IMMUNE RESPONSE AND USE THEREOF

摘要

The present invention relates to peptides stimulating anti-tumor immune response, wherein said peptides bind to a human major histocompatibility complex (MHC) class I or II, and wherein said peptides are capable of stimulating CD4 and/or CD8 T cells, and to the use thereof in vaccines for the treatment of cancer. The present invention also relates to nucleic acids encoding said peptides, vectors expressing said peptides, host cells comprising said nucleic acids, and to the use thereof in vaccines for the treatment of cancer, as well as to methods for producing said peptides and activated cytotoxic T lymphocytes and to kits for inducing anti-tumor immune response.